Language:
USA
Indena Indena's Centenary
Back

Products

100+ years of botanical excellence mean a wide range of botanical derivatives. Search for them.

Go to section
Back

Things to watch

Go to section
Back

Media and news

Here is the right place where you can read all the latest news and information about Indena’s world.

Events

Take a look on Indena’s Calendar. You will always be aware of our upcoming events.

Indena’s Filestore

Browse all Indena’s documents about products, events, company information and so much more.

Go to section
Indena at CPHI: at the heart of pharma, with your challenges in mind

NEWS / 23 Oct 2023

Indena at CPHI: at the heart of pharma, with your challenges in mind

Scroll to see more

Visit Booth 7H40 to meet Indena and gain a partner!

With 100+ years of botanical excellence in our history and a future-ready vision of the pharmaceutical industry, we are the ideal partner for companies seeking the utmost quality and innovation to win the challenges in today’s market.
Come meet Indena’s bright minds and experts on October 24-26 at CPhI Barcelona, to find out more about our proactive customer-centric approach, long-term commitment to sustainability, and of course our breakthrough products.

Discover the next-generation of CDMO services

Over the years, we have accrued remarkable experience as a CDMO implementing high-containment solution for new high potent NCEs: we currently manufacture 12 commercial HPAPIs of synthetic, semi-synthetic and fermentation origin. We constantly invest in our state-of-the-art equipment, which includes a multi-purpose GMP plant, spray dryers using organic solvents, and industrial suites with dozens of meters of glove boxes.

That’s why, at Indena, we have the open attitude, scientific knowledge and top-notch infrastructure to help you take a leap forward. Like we did with Australian company Qbiotics, scaling the lab process up to industrial level after they identified an oncological candidate through a cutting-edge mechanism inspired by biodiversity and the ecosystem.

What’s next? At the beginning of 2024, we will inaugurate a whole new R&D area to help our clients push pharmaceutical innovation even further.

Discover more
Discover the next-generation of CDMO services

Ensure business continuity within a framework of sustainability

We share with our partners a century of commitment to sustainability and responsible actions for people and the planet. A few examples?

– Our solid supply chain is built on strong values and a long-term vision, as we strive to extend our positive impact to the communities that live where the plants we use are grown.

– All of our factories in Europe are certified according to ISO 14001 Environmental Management System and ISO 45001 Occupational Health and Safety Management System.

– We take steps to reduce CO2 emissions and foster the energy transition, equipping our sites with high-efficiency photovoltaic panels to self-produce 67% of energy and generate 23% from renewable sources by the end of this year.

In addition to contributing to the planet’s wellbeing, all our actions in favor of sustainability make us more reliable in terms of business continuity, and finally better partners for your success.

Discover more
Ensure business continuity within a framework of sustainability

Pick – or develop – the best ingredients for your needs

We have developed an extensive catalog of pharmaceutical ingredients, including traditional generic APIs for the health of humankind. Taxanes, Gloriosa, Saw Palmetto, Cannabidiol, and more: each one confirms our botanical excellence and allows us to provide the best solution for every need.

Our proven track record as innovators in the field shows we are able to overcome any obstacle to develop new solutions. Case in point: in the 1990s, we started our own yew plantation to create a sustainable, commercial-scale supply chain for the first oncological blockbuster drug, Paclitaxel, extracted from the tree’s bark. We also invented a new industrial method do extract and purify the intermediate 10-Deacetylbaccatin III, devised a robust analytical frame in compliance with stringent regulations, and refined our own synthetic methods to convert 10-Deacetylbaccatin III into the final API. Our combination of expertise, insight and determination makes us your best partners when developing pharmaceutical innovation is a challenge.

Discover more
Pick – or develop – the best ingredients for your needs

READ THE FULL PRESS RELEASE HERE.

Indena - Science is our nature

Sorry, our website doesn't support IE11 and older versions

For a better experience try a modern browser:

Indena

This is a private file, to request the download of this resource, please fullfill the fields below.